Scientists have discovered a potential biomarker that could more accurately identify which patients with non-hypermutated cancers will respond to specialized immunotherapy drugs called immune ...
In a new National Institutes of Health-funded research report, scientists at Johns Hopkins Medicine say they have identified a potential target for drugs that could dial up or down the activity of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback